These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Description of the Pathogenic Features of Streptococcus pyogenes Isolates from Invasive and Non-Invasive Diseases in Aichi, Japan. Matsumoto M; Yamada K; Suzuki M; Adachi H; Kobayashi S; Yamashita T; Minagawa H; Tatsuno I; Hasegawa T Jpn J Infect Dis; 2016 Jul; 69(4):338-41. PubMed ID: 26567838 [TBL] [Abstract][Full Text] [Related]
23. Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. Kiska DL; Thiede B; Caracciolo J; Jordan M; Johnson D; Kaplan EL; Gruninger RP; Lohr JA; Gilligan PH; Denny FW J Infect Dis; 1997 Oct; 176(4):992-1000. PubMed ID: 9333158 [TBL] [Abstract][Full Text] [Related]
24. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Musser JM; Hauser AR; Kim MH; Schlievert PM; Nelson K; Selander RK Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2668-72. PubMed ID: 1672766 [TBL] [Abstract][Full Text] [Related]
25. Detection of circulating bacterial superantigen and lymphotoxin-alpha in patients with streptococcal toxic-shock syndrome. Sriskandan S; Moyes D; Cohen J Lancet; 1996 Nov; 348(9037):1315-6. PubMed ID: 8909404 [No Abstract] [Full Text] [Related]
26. T serotyping of group a streptococcus isolated from patients with pharyngitis or streptococcal toxic shock syndrome in Japan between 2005 and 2017. Ikebe T; Okuno R; Uchitani Y; Kanda Y; Sasaki M; Uchida K; Chiba K; Yamaguchi T; Otsuka H; Suzuki M; Ohya H; Watanabe H; Ohnishi M; J Infect Chemother; 2020 Feb; 26(2):157-161. PubMed ID: 31735631 [TBL] [Abstract][Full Text] [Related]
27. Streptococcal toxic shock syndrome caused by the dissemination of an invasive emm3/ST15 strain of Streptococcus pyogenes. Sekizuka T; Nai E; Yoshida T; Endo S; Hamajima E; Akiyama S; Ikuta Y; Obana N; Kawaguchi T; Hayashi K; Noda M; Sumita T; Kokaji M; Katori T; Hashino M; Oba K; Kuroda M BMC Infect Dis; 2017 Dec; 17(1):774. PubMed ID: 29254479 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of the speA2 and speA3 alleles in Streptococcus pyogenes isolated from TSLS patients in Japan. Matsumoto M; Murai T; Ichiyama S; Saito M; Arakawa Y; Ohta M FEMS Microbiol Lett; 1997 May; 150(2):233-7. PubMed ID: 9170267 [TBL] [Abstract][Full Text] [Related]
30. Streptococcal pyrogenic exotoxin G gene in blood and pharyngeal isolates of Streptococcus dysgalactiae subspecies equisimilis has a limited role in pathogenesis. Korem M; Hidalgo-Grass C; Michael-Gayego A; Nir-Paz R; Salameh S; Moses AE J Microbiol Immunol Infect; 2014 Aug; 47(4):292-6. PubMed ID: 23380619 [TBL] [Abstract][Full Text] [Related]
31. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Cleary PP; Kaplan EL; Handley JP; Wlazlo A; Kim MH; Hauser AR; Schlievert PM Lancet; 1992 Feb; 339(8792):518-21. PubMed ID: 1346879 [TBL] [Abstract][Full Text] [Related]
32. Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: results from a nationwide study. Ekelund K; Skinhøj P; Madsen J; Konradsen HB J Clin Microbiol; 2005 Apr; 43(4):1789-96. PubMed ID: 15815000 [TBL] [Abstract][Full Text] [Related]
33. Group A streptococcal infections in France. Clinical features and epidemiological markers. The Groupe d'Enquête 1995 sur les Infections Streptococciques. Varon E; Havlickova H; Gires A; Sarr A; Pitman C; Patey O; Goupy F; Kriz P; Bouvet A Adv Exp Med Biol; 1997; 418():229-31. PubMed ID: 9331639 [No Abstract] [Full Text] [Related]
34. Molecular characterization and antibiotic resistance of Streptococcus dysgalactiae subspecies equisimilis isolated from patients with streptococcal toxic shock syndrome. Ikebe T; Okuno R; Sasaki M; Kanda Y; Otsuka H; Kawahara R; Ohya H; Suzuki M; Uchida K; Nihonmatsu H; Ohnishi M; J Infect Chemother; 2018 Feb; 24(2):117-122. PubMed ID: 29107650 [TBL] [Abstract][Full Text] [Related]
35. Complete genome sequence of Streptococcus pyogenes M1 476, isolated from a patient with streptococcal toxic shock syndrome. Miyoshi-Akiyama T; Watanabe S; Kirikae T J Bacteriol; 2012 Oct; 194(19):5466. PubMed ID: 22965090 [TBL] [Abstract][Full Text] [Related]
36. Unraveling the mysteries of streptococci and their relations with the host. Ferrieri P; Horaud T Trends Microbiol; 1997 Jan; 5(1):5-7. PubMed ID: 9025228 [No Abstract] [Full Text] [Related]
37. Clinical and microbiologic characteristics of invasive Streptococcus pyogenes infections in north and south India. Haggar A; Nerlich A; Kumar R; Abraham VJ; Brahmadathan KN; Ray P; Dhanda V; Joshua JM; Mehra N; Bergmann R; Chhatwal GS; Norrby-Teglund A J Clin Microbiol; 2012 May; 50(5):1626-31. PubMed ID: 22357508 [TBL] [Abstract][Full Text] [Related]
38. Invasive group A streptococcal infections. Serotype newly associated with toxic shock-like syndrome in Trinidad. Swanston WH; Woo J; Murphy A; Efstratiou A; Tanna A; Reid HF Adv Exp Med Biol; 1997; 418():71-3. PubMed ID: 9331602 [No Abstract] [Full Text] [Related]
39. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Demers B; Simor AE; Vellend H; Schlievert PM; Byrne S; Jamieson F; Walmsley S; Low DE Clin Infect Dis; 1993 Jun; 16(6):792-800; discussion 801-2. PubMed ID: 8329511 [TBL] [Abstract][Full Text] [Related]
40. Toxic shock syndrome due to group A streptococcal pharyngitis and bacteremia in an adult. Vucicevic Z; Bencic IJ; Kruslin B; Degoricija V J Microbiol Immunol Infect; 2008 Aug; 41(4):351-4. PubMed ID: 18787744 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]